Negative-pressure Wound Therapy (NPWT) Industry - Regional Synopsis
Regionally, the negative-pressure wound therapy (NPWT) market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is predicted to hold largest revenue share by 2037, backed by rise in occurrence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers with the increase in geriatric population, increasing healthcare expenditure, and expanding research and development (R&D) activities in the region. According to the Centers for Medicare & Medicaid Services, national health expenditure is expected to rise by 5.1% per year from 2021 to 2030, reaching nearly USD 6.8 trillion.
 Market.jpg)
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of negative-pressure wound therapy is estimated at USD 2.88 billion.
Negative-pressure Wound Therapy (NPWT) Market size was valued at USD 2.73 billion in 2024 and is likely to cross USD 6.19 billion by 2037, registering more than 6.5% CAGR during the forecast period i.e., between 2025-2037.
North America industry is estimated to hold largest revenue share by 2037, backed by rise in occurrence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers with the increase in geriatric population, increasing healthcare expenditure, and expanding research and development (R&D) activities in the region.
The major players in the market are Smith & Nephew, PLC, Acelity L.P., Inc., Cardinal Health, DeRoyal Industries Inc., Genadyne Biotechnologies, Inc., Medela, LLC., ConvaTec, Inc., ATMOS MedizinTechnik, GmbH & Co. KG, and others.
